Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.
Zhang Y, Pitchiaya S, Cieślik M, Niknafs YS, Tien JC, Hosono Y, Iyer MK, Yazdani S, Subramaniam S, Shukla SK, Jiang X, Wang L, Liu TY, Uhl M, Gawronski AR, Qiao Y, Xiao L, Dhanasekaran SM, Juckette KM, Kunju LP, Cao X, Patel U, Batish M, Shukla GC, Paulsen MT, Ljungman M, Jiang H, Mehra R, Backofen R, Sahinalp CS, Freier SM, Watt AT, Guo S, Wei JT, Feng FY, Malik R, Chinnaiyan AM. Zhang Y, et al. Among authors: wei jt. Nat Genet. 2018 Jun;50(6):814-824. doi: 10.1038/s41588-018-0120-1. Epub 2018 May 28. Nat Genet. 2018. PMID: 29808028 Free PMC article.
Elevated alpha-methylacyl-CoA racemase enzymatic activity in prostate cancer.
Kumar-Sinha C, Shah RB, Laxman B, Tomlins SA, Harwood J, Schmitz W, Conzelmann E, Sanda MG, Wei JT, Rubin MA, Chinnaiyan AM. Kumar-Sinha C, et al. Among authors: wei jt. Am J Pathol. 2004 Mar;164(3):787-93. doi: 10.1016/s0002-9440(10)63167-7. Am J Pathol. 2004. PMID: 14982833 Free PMC article.
Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death.
Rubin MA, Bismar TA, Andrén O, Mucci L, Kim R, Shen R, Ghosh D, Wei JT, Chinnaiyan AM, Adami HO, Kantoff PW, Johansson JE. Rubin MA, et al. Among authors: wei jt. Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1424-32. doi: 10.1158/1055-9965.EPI-04-0801. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15941951
Autoantibody signatures in prostate cancer.
Wang X, Yu J, Sreekumar A, Varambally S, Shen R, Giacherio D, Mehra R, Montie JE, Pienta KJ, Sanda MG, Kantoff PW, Rubin MA, Wei JT, Ghosh D, Chinnaiyan AM. Wang X, et al. Among authors: wei jt. N Engl J Med. 2005 Sep 22;353(12):1224-35. doi: 10.1056/NEJMoa051931. N Engl J Med. 2005. PMID: 16177248 Free article.
Integrative molecular concept modeling of prostate cancer progression.
Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, Shah RB, Chinnaiyan AM. Tomlins SA, et al. Among authors: wei jt. Nat Genet. 2007 Jan;39(1):41-51. doi: 10.1038/ng1935. Epub 2006 Dec 17. Nat Genet. 2007. PMID: 17173048
Humoral response profiling reveals pathways to prostate cancer progression.
Taylor BS, Pal M, Yu J, Laxman B, Kalyana-Sundaram S, Zhao R, Menon A, Wei JT, Nesvizhskii AI, Ghosh D, Omenn GS, Lubman DM, Chinnaiyan AM, Sreekumar A. Taylor BS, et al. Among authors: wei jt. Mol Cell Proteomics. 2008 Mar;7(3):600-11. doi: 10.1074/mcp.M700263-MCP200. Epub 2007 Dec 11. Mol Cell Proteomics. 2008. PMID: 18077443 Free article.
383 results